Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Safety Data Sheet
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
An Immunized and Synthetic Approach to Antibody Discovery for GPCR C5aR1-Biopharma Awareness
Monoclonal antibodies are an increasingly important source for novel therapeutics, however, bringing one to market is far from trivial. Twist Biopharma Solutions is helping researchers improve their odds of success in antibody discovery and optimization by combining immunization and synthetic approaches. This study illustrates the power of Twists ability to generate robust immune libraries leveraging both in vivo and in vitro workflows.
Covered in this Flyer
Recent study highlighting Twist researchers used a dual antibody discovery approach
Explanation of the discovery process for difficult-to-target high-affinity, humanized anti C5aR1 antibodies
Benefits of using a dual approach to antibody discovery
